JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Antibiotic efficacy is most commonly determined by conducting killing kinetic studies and measuring colony forming units (CFUs). By integrating scanning electron microscopy (SEM) with these standard methods, we can distinguish the pharmacological effects of treatment between different antibiotics.

Streszczenie

Assessment of antibiotic action with new drug development directed towards anaerobic bacteria is difficult and technically demanding. To gain insight into possible MOA, morphologic changes associated with antibiotic exposure can be visualized using scanning electron microscopy (SEM). Integrating SEM imaging with traditional kill curves may improve our insight into drug action and advance the drug development process. To test this premise, kill curves and SEM studies were conducted using drugs with known but different MOA (vancomycin and metronidazole). C. difficile cells (R20291) were grown with or without the presence of antibiotic for up to 48 h. Throughout the 48 h interval, cells were collected at multiple time points to determine antibiotic efficacy and for imaging on the SEM. Consistent with previous reports, vancomycin and metronidazole had significant bactericidal activity following 24 h of treatment as measured by colony-forming unit (CFU) counting. Using SEM imaging we determined that metronidazole had significant effects on cell length (> 50% reduction in cell length for each antibiotic; P< 0.05) compared to controls and vancomycin. While the phenotypic response to drug treatment has not been documented previously in this manner, they are consistent with the drug's MOA demonstrating the versatility and reliability of the imaging and measurements and the application of this technique for other experimental compounds.

Wprowadzenie

Clostridium difficile is a gram positive, spore-forming bacterium, causing approximately 500,000 infections annually in the US and is considered a threat level urgent pathogen by the Centers for Disease Control and Prevention (CDC), the highest level of risk.1 The past decade has seen considerable drug development in antimicrobials with activity against C. difficile.2,3In vitro studies are a necessary component of the drug development process.4 Traditionally, in vitro susceptibility and time kill studies are used to validate future animal and other in vivo studies.

While these methods serve an important role for evaluating killing action, they do not capture the cells' phenotypic response to pharmacological treatment. By incorporating scanning electron microscopy (SEM) with standard killing kinetic studies, a more thorough characterization of the antibiotic direct effects is possible.5,6,7 Here, we present a method where SEM is used as a means to profile the efficacy of antibiotic treatment.

Protokół

1. Isolating C. difficile from Different Environmental or Clinical Sources

  1. Environmental isolates: Using a pre-sterilized cotton gauge (lightly wetted with 0.85% NaCl), swab the surface of any area of interest (floor, door, handle, shelf, etc.).8 Make sure to wear sterile gloves and place the swab in a sterilized tube after completed.
  2. Clinical isolates (stool): Plate 10 to 100 mg of clinical stool samples onto cefoxitin-cycloserine-fructose agar (CCFA) using an inoculation loop and incubate under strict anaerobic conditions for 48 - 72 h. Store isolated colonies of C. difficile stock in cryovials at -80 °C for further analyses.7,9,10
  3. Enrich the environmental swab samples in brain heart infusion (BHI) broth with 0.05% sodium taurocholate and place in an anaerobic chamber at 37 °C for 5 days. Centrifuge 1 mL of the culture at 10,000 x g and resuspend the pellet in 100 µL of ethanol.
  4. Plate the resuspended cells (50 µL) onto cycloserinecefoxitin fructose agar (CCFA) plates and incubate in an anaerobic chamber at 37 °C for 40 - 48 h. Store isolated colonies of C. difficile stock in cryovials at -80 °C for further analyses.
  5. Test suspected C. difficile colonies using the latex agglutination reagent or PCR.

2. Culturing C. difficile and Killing Kinetic Procedures

  1. Grow purified environmental or clinical C. difficile strains on blood agar plates in an anaerobic chamber at 37 °C for 48 h.
  2. Take one isolated colony with an inoculation loop, transfer it into 5 mL BHI medium in a 15 mL tube, and grow for 24 h in an anaerobic chamber at 37 °C .
  3. Dilute the pre-cultures 1:100 to approximately 106 colony-forming units (CFU)/mL in fresh pre-reduced BHIS (BHI plus 5 g/L yeast extract and 1% L-cysteine) supplemented with 0.1% sodium taurocholate and the appropriate concentration of antibiotic (T0).
  4. Collect a 1 mL sample with a pipette at each time point (T0, T6, T24, T48) and plate/spread a small aliquot (100 µL in serial dilutions) onto a blood agar plate. Let the cells grow on the blood agar plate for 48 h in an anaerobic chamber at 37 °C and count the resulting number of colonies to determine CFU.

3. Preparing Samples for Scanning Electron Microscopy

  1. Collect 1 mL of cells from each time point in microcentrifuge tubes and centrifuge at 10,000 x g for 10 min. Discard the supernatant and wash cells in PBS.
  2. Centrifuge the samples at 10,000 x g for 10 min again and discard the supernatant. Re-dilute cells in 1 mL of 4% paraformaldehyde and incubate for 1 h at room temperature.
  3. Centrifuge samples again for 10 min at 10,000 x g and discard supernatant. Wash cells twice with distilled water and redilute in 100 µL of distilled water. Adjust volume depending on the turbidity of the solution.
    NOTE: Making multiple serial dilutions is a good idea.
  4. Label coverslips and add 40 µL of the sample on it. Incubate for 15 min in a flow hood to evaporate the liquid and allow the cells to adhere to the coverslip. If liquid is still present, use a blower to remove the liquid.
  5. Place labeled coverslips with cells in a desk sputtering machine and tape down. Secure pure gold in the sputtering machine. Turn machine on and commence sputtering at low pressure (50 mTorr). Coat cells for 30 s at 80 mA, which translates to 20 nm of gold coating.
  6. Transfer coated cells to the scanning electron microscope.

4. Imaging C. difficile Cells on a Scanning Electron Microscope

  1. Vent the scanning electron microscope (SEM) properly by pressing the vent button on the computer software.
  2. Using carbon tape, secure the coated coverslips onto the metal stage. Once the SEM is vented, the door should easily open. Lock the metal stage into the SEM chamber by screwing it in.
  3. Click the PUMP button on the computer software. The SEM will be useable when the system reads "Vac OK".
  4. Click on the SE detector under the detectors tab. Turn on the beam by clicking on the button that displays the voltage. Start imaging at a lower voltage (5 kV) before increasing voltage (up to 15 kV). An image will appear after the beam is turned on.
  5. Using the tracking function, find an area on the coated coverslips to image. Zoom into the region and find rod-shaped structures; these are clostridium difficile.
  6. Zoom in and focus the image to calibrate the system. This should be done at multiple working distances: 15, 9 and 5 mm. Image at a working distance of 5 mm.
  7. Switch on the ultra high resolution imaging mode and begin to focus and optimize astigmatism.
  8. Begin to focus at high magnification. Use the coarse and fine focus toggles for this. Adjust astigmatism as well to obtain a clearer image.
    1. Adjust astigmatism at high magnification. To do this, adjust the astigmatism toggles (they look similar to the fine/coarse focus toggles) and check the image for clarity by digitally zooming in on the computer software.
  9. se the slow scan function to collect a high quality image. Save the collected image as a .TIFF file, which will be used for analysis. Make sure the data bar is selected if measurements will be made during analysis.
  10. Collect images at different angles (up to 52° by manually turning the angle directly on the SEM. Angled images tend to reveal more depth information.
  11. Change beam voltage depending on the cells that are being imaged. Keep this mostly between 5 - 15 kV for all experiments.
  12. After imaging is completed, turn the beam off and raise the working distance to 20 mm. The chamber can then be vented and the stage can be removed. Copy all of the images onto a drive for further analysis.

5. Image Processing and Analysis

  1. Download and install the freely available software, FIJI (http://fiji.sc), on to the computer.
  2. Open the image file in FIJI.
  3. Using the line function, precisely trace the scale bar.
  4. Click on the Analyze tab in the FIJI program and finally select the Select Scale function. A window will appear that will require the setting of the known distance based on the scale bar. Change the unit of length as well and click OK.
  5. Now that the program is calibrated for distance, use the line function to measure cell length. To obtain the length, use the line function to trace the cell in its entirety. Select the Analyze tab again and then click on Measure. The length should appear in the units denoted previously.

Wyniki

Clostridium difficile is a spore-forming bacterium and thus it is essential to determine the morphology differences between vegetative and spore cells prior to any functional analysis. Figure 1 demonstrates representative images of vegetative cells that were captured during the exponential phase of the growth curve and spore cells. As depicted, vegetative cells are long, smooth, rod-shaped structures whereas spores are small, oval structures that have a rough ext...

Dyskusje

The goal of the current study was to create a high-throughput method for isolating C. difficile and testing antibiotic susceptibility using scanning electron microscopy (SEM) as a means for a more thorough characterization of the antibiotic's pharmacological action. Using the protocols outlined here, we have demonstrated that imaging the cell's phenotypic response to antibiotic treatment can reveal insight into the pharmacological action of the drug. In total, the imaging portion of this protocol takes r...

Ujawnienia

KWG has received past and current research support from Merck & Co. and Summit, PLC.

Podziękowania

These experiments have been supported by research grants from Merck and Co. and Summit, PLC.

Materiały

NameCompanyCatalog NumberComments
cotton gauze CaringPRM21408C
NaClMacron7532
50 mL tubesFalcon352098
Brain Heart Infusion (BHI) CriterionC5141
L-cysteineAlfa AesarA10389
yeast extractCriterionC741
sodium taurocholateAlfa AesarA18346
anaerobic chamberCoyvinyl anaerobic chamber
cycloserinecefoxitin fructose agar (CCFA) platesAnaerobe systemsAS-213
blood agar platesHardy diagnosticsA-10
latex agglutination reagentOxoidDR1107AC. diff test kit
microcentrifuge tubesEppendorf222363204
PBSGibco10010-031
4% paraformaldehydeFisher Scientific50-259-98
microscope slidesJ. Melvin freed brand7525M75 x 25mm
flow hoodLabconcoClass II type A2 biosafety cabinet
desk sputtering machineDenton VacuumDesk II
tapePlastic Core05072-ABSPI Double Sided Adhesive Carbon Tape
goldDenton VacuumTAR001-01582.375” Diameter x .002” Thick Gold foil
scanning electron microscopeFEIXL-30

Odniesienia

  1. Lessa, F. C., et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 372 (9), 825-834 (2015).
  2. Vickers, R. J., et al. Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents. 48 (2), 137-143 (2016).
  3. Shah, D., et al. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther. 8 (5), 555-564 (2010).
  4. Ambrose, P. G., et al. New EMA guideline for antimicrobial development. Lancet Infect Dis. 12 (4), 265-266 (2012).
  5. Bassères, E., et al. Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection. J Antimicrob Chemother. 71 (5), 1245-1251 (2016).
  6. Endres, B. T., et al. A novel method for imaging the pharmacological effects of antibiotic treatment on Clostridium difficile. Anaerobe. 40, 10-14 (2016).
  7. Endres, B. T., et al. Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes. Antimicrob Agents Chemother. 60 (6), 3519-3523 (2016).
  8. Alam, M. J., Anu, A., Walk, S. T., Garey, K. W. Investigation of potentially pathogenic Clostridium difficile contamination in household environs. Anaerobe. 27, 31-33 (2014).
  9. Aitken, S. L., et al. In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent. Infect Control Hosp Epidemiol. , 1-6 (2015).
  10. Basseres, E., et al. Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection. J Antimicrob Chemother. 71 (5), 1245-1251 (2016).
  11. Walters, B. A., Roberts, R., Stafford, R., Seneviratne, E. Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy. Gut. 24 (3), 206-212 (1983).
  12. Chilton, C. H., et al. Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery. J Antimicrob Chemother. 68 (9), 2078-2082 (2013).
  13. Ofosu, A. Clostridium difficile infection: a review of current and emerging therapies. Ann Gastroenterol. 29 (2), 147-154 (2016).
  14. McDonald, L. C., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. New Eng J Med. 353 (23), 2433-2441 (2005).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Clostridium DifficileAntibiotic TreatmentMorphological ChangesMicrobiological ImagingScanning Electron MicroscopyPharmacological Killing ActionClostridium Difficile Infection CDIEnvironmental IsolatesClinical IsolatesCCFAAnaerobic ConditionsCryopreservation

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone